Navigation Links
FDA Approves NOVO NORDISK's NovoSeven(R) RT (Coagulation Factor VIIa [Recombinant] Room Temperature Stable) for Hemophilia Patients With Inhibitors
Date:5/13/2008

ey're taking NovoSeven(R) may be at increased risk for thrombosis. Serious adverse events which may or may not have been related to the use of NovoSeven(R) occurred in 14 of the 298 patients in the initial clinical program. There have been no reports of NovoSeven(R) causing bad reactions to "analgesics" (such as pain killers), "antibiotics" (the drugs used to treat infection), or "sedatives" (sleeping pills or tranquilizers). Development of antibodies against Factor VII has been reported in Factor VII-deficient patients after treatment with NovoSeven(R). These patients had previously been treated with human plasma and/or plasma-derived Factor VII.

About Novo Nordisk

Novo Nordisk is a health care company and a world leader in diabetes care. The company has the broadest diabetes product portfolio in the industry, including the most advanced products within the area of insulin delivery systems. In addition, Novo Nordisk has a leading position within areas such as hemostasis management, growth hormone therapy, and hormone replacement therapy.

Novo Nordisk manufactures and markets pharmaceutical products and services that make a significant difference to patients, the medical profession, and society. With headquarters in Denmark, Novo Nordisk employs more than 23,600 employees in 79 countries and markets its products in 179 countries. Novo Nordisk's B shares are listed on the stock exchanges in Copenhagen and London. Its ADRs are listed on the New York Stock Exchange under the symbol 'NVO'. For more information, visit novonordisk.com.

Media

Sean Clements

Novo Nordisk

PH: (609) 514-8316


'/>"/>
SOURCE Novo Nordisk
Copyright©2008 PR Newswire.
All rights reserved

3

GOOD

Page: 1 2 3 4

Related medicine news :

1. FDA Approves Taclonex Scalp(R) - Once Daily Therapy for Treatment of Moderate to Severe Scalp Psoriasis
2. FDA Approves Health Claim for Brown Rice
3. FDA Approves Strattera(R) for Maintenance of ADHD in Children and Adolescents
4. FDA approves HeartMate II mechanical heart pump for heart-failure patients
5. FDA Approves Advair(R) 250/50 for Reduction of Exacerbations in Patients With COPD
6. FDA Approves New Once-a-Month Dose of Actonel for Postmenopausal Osteoporosis
7. FDA approves VYVANSE, first and only once-daily prodrug stimulant to treat ADHD in adults
8. FDA APPROVES ROTARIX(R) [Rotavirus Vaccine, live, oral], THE FIRST VACCINE LICENSED TO COMPLETE THE ROTAVIRUS IMMUNIZATION SERIES BY FOUR MONTHS OF AGE
9. House Overwhelmingly Approves Renewal and Tripling of Successful U.S. Global AIDS Prevention Effort
10. VeriPrime Approves New Best Practices for Beef Production
11. U.S. EPA Approves Registration of Antimicrobial Copper Alloys
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... DNA of a 1st century shrouded man found in a ... has revealed the earliest proven case of leprosy. Details of ... PloS ONE Journal. , The molecular investigation was undertaken ... the Sanford F. Kuvin Center for the Study of Infectious ... Carney Matheson and Ms. Kim Vernon of Lakehead University, Canada, ...
(Date:12/16/2009)... the families of sick and dying hospitalized children ask ... How do pediatricians respond to such personal requests? While ... help some patients and families cope with serious illness, ... the families and patients who raise the issue of ... issue of Southern Medical Journal , Brandeis and ...
(Date:12/16/2009)... million screenings conducted through national AAD program ... One person dies from melanoma, the deadliest form ... is often successfully treated, if caught early. That,s ... free skin cancer screenings in their communities through ... Cancer Screening Program. The program recently reached a ...
(Date:12/16/2009)... Medizone International, Inc. (OTC Bulletin Board: MZEI) ... the Board of Medizone New Zealand Ltd., a ... a 50% interest, agreed on December 14, 2009 ... Medizone International all global marketing rights of the ... G. Marshall said, "Time has eroded the relevance ...
(Date:12/16/2009)... to patient information could improve care, but privacy ... (HealthDay News) -- U.S. physicians support the use ... about privacy problems, two new studies show. , ... and specialist doctors in Massachusetts found that 86 ... improve patient quality of care, 70 percent thought ...
Breaking Medicine News(10 mins):Health News:DNA of Jesus-era shrouded man in Jerusalem reveals earliest case of leprosy 2Health News:DNA of Jesus-era shrouded man in Jerusalem reveals earliest case of leprosy 3Health News:Prayer on the hospital floor 2Health News:Dermatologists Reach Skin Cancer Screening Milestone 2Health News:Dermatologists Reach Skin Cancer Screening Milestone 3Health News:Medizone International, Inc. Approves Repurchase of Global Marketing Rights 2Health News:Pros and Cons of Electronic Medical Records Weighed 2
... CHAPEL HILL, N.C., April 16 Top Performers ... and,efficiency data -- when-possible and submit them for ... to raise awareness on key,humanistic and Quality of ... evidence based Guidelines and customize to managed care,organizations., ...
... Provide Revenue Cycle Solutions for ... Historic, 150 Year-Old Institution, PLANO, Texas, ... announced a new seven-year Revenue Cycle,Solutions agreement with New York ... Cycle Solutions that will,provide management and patient financial service professionals ...
... for aggressive breast cancer,Well-documented breast cancer tissue collection meets ... , Mammography and biopsies help find breast cancer, but ... will spread. Now, a two-year research project hopes to ... patients harboring not just breast cancer, but the nastiest ...
... Jenni Schaefer, a young,woman in Tennessee who ... to become a well-known motivational speaker, author, singer,songwriter ... been,appointed to the Ambassador Council of the National ... Schaefer will continue her travels nationally and,internationally, speaking ...
... According to New NCPA,Study, DALLAS, April 16 ... on low-income workers when they work,extra hours to get ... Center for Policy Analysis., "The impact on low-income ... Fellow Laurence Kotlikoff, Boston University,professor and author of the ...
... As potential cancer therapies proliferate, researchers and clinicians ... accurately predict which patients will receive the most benefit. ... Annual Meeting, April 12-16, 2008, researchers present data on ... doctors can more effectively measure response to commonly used ...
Other Medicine News:Health News:Perot Systems Selected to Implement Revenue Cycle Solution for New York Downtown Hospital 2Health News:Perot Systems Selected to Implement Revenue Cycle Solution for New York Downtown Hospital 3Health News:Research collaboration seeks blood test for aggressive breast cancer 2Health News:Research collaboration seeks blood test for aggressive breast cancer 3Health News:Jenni Schaefer, Motivational Speaker, Author Named National Eating Disorders Association (NEDA) Ambassador 2Health News:Tax Rates Mean Extra Work Doesn't Pay 2Health News:Measuring medicine: How new technologies could help doctors predict patient outcomes 2Health News:Measuring medicine: How new technologies could help doctors predict patient outcomes 3Health News:Measuring medicine: How new technologies could help doctors predict patient outcomes 4Health News:Measuring medicine: How new technologies could help doctors predict patient outcomes 5Health News:Measuring medicine: How new technologies could help doctors predict patient outcomes 6
(Date:12/16/2009)... LYON, France, Dec. 16 /PRNewswire/ -- ... the sanofi-aventis Group, announced today that it ... agreement with Syntiron to develop and commercialize ... including Methicillin-Resistant Staphylococcus aureus or ... infections in humans, sometimes referred to as ...
(Date:12/16/2009)... Lower Prescription Drug Prices ,, CHICAGO, Dec. ... night rejected an amendment to the Patient Protection ... prescription drugs more affordable by allowing for the ... from abroad. The bipartisan amendment, endorsed by ... Grassley and Stabenow, would have improved competition and ...
(Date:12/16/2009)... Ill., Dec. 16 Naurex Inc., a ... depression and other CNS disorders based on its ... it has initiated a Phase I clinical trial ... dosed the first subjects in the study. ... selective modulator of the NMDA receptor, is initially ...
Breaking Medicine Technology:Sanofi Pasteur Obtains License from Syntiron to Develop & Commercialize Vaccine to Prevent Staphylococcus Infections 2Sanofi Pasteur Obtains License from Syntiron to Develop & Commercialize Vaccine to Prevent Staphylococcus Infections 3Sanofi Pasteur Obtains License from Syntiron to Develop & Commercialize Vaccine to Prevent Staphylococcus Infections 4AARP Illinois Key Vote News Alert 2Naurex Inc. Initiates Phase I Clinical Trial of its Novel Mechanism NMDA Modulator GLYX-13 in Treatment-Resistant Depression 2Naurex Inc. Initiates Phase I Clinical Trial of its Novel Mechanism NMDA Modulator GLYX-13 in Treatment-Resistant Depression 3Former Connecticut Governor Lowell Weicker Jr Delivers Address on Health Reform 60458 1Former Connecticut Governor Lowell Weicker Jr Delivers Address on Health Reform 60458 2Former Connecticut Governor Lowell Weicker Jr Delivers Address on Health Reform 60458 3Women with chronic kidney disease more likely than men to go undiagnosed 60456 1Women with chronic kidney disease more likely than men to go undiagnosed 60456 2GE Healthcare President 26 CEO Mark Vachon to Present at BioConference Live 10595 1GE Healthcare President 26 CEO Mark Vachon to Present at BioConference Live 10595 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: